Skip to main content

Psychiatric and Psychosocial Factors in Low Vision Rehabilitation

  • Living reference work entry
  • First Online:
Albert and Jakobiec's Principles and Practice of Ophthalmology

Abstract

The prevalence of vision impairment increases with advancing age. There are few treatment options to restore vision to its premorbid level in most age-related eye diseases (e.g., diabetic retinopathy [DR], age-related macular degeneration [AMD], glaucoma), and thus low vision rehabilitation is the most promising treatment to improve visual functioning and help people cope with vision-related disability. Effective provision of low vision rehabilitation requires an understanding of the psychosocial and psychiatric factors confronted by older people and how these factors may interact with late onset vision loss. Depression and cognitive impairment, distinct but oftentimes comorbid conditions, are the most common psychiatric disorders affecting older people with impaired vision.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–8.

    Article  PubMed  Google Scholar 

  2. Varma R, Vajaranant TS, Burkemper B, Wu S, Torres M, Hsu C, Choudhury F, McKean-Cowdin R. Visual impairment and blindness in adults in the United States: demographic and geographic variations from 2015 to 2050. JAMA Ophthalmol. 2016;134(7):802–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jacobs JM, Hammerman-Rozenberg R, Maaravi Y, Cohen A, Stessman J. The impact of visual impairment on health, function and mortality. Aging Clin Exp Res. 2005;17(4):281–6.

    Article  PubMed  Google Scholar 

  4. Kempen GI, Ballemans J, Ranchor AV, van Rens GH, Zijlstra GA. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services. Qual Life Res. 2012;21(8):1405–11.

    Article  PubMed  Google Scholar 

  5. Crews JE, Campbell VA. Vision impairment and hearing loss among community-dwelling older Americans: implications for health and functioning. Am J Public Health. 2004;94:823–9.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Tournier M, Moride Y, Ducruet T, Moshyk A, Rochon S. Depression and mortality in the visually-impaired, community-dwelling, elderly population of Quebec. Acta Ophthalmol. 2008;86(2):196–201.

    Article  PubMed  Google Scholar 

  7. Zheng DD, Christ SL, Lam BL, Arheart KL, Galor A, Lee DJ. Increased mortality risk among the visually impaired: the roles of mental well-being and preventive care practices. Invest Ophthalmol Vis Sci. 2012;53(6):2685–92.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Morse AR, Seiple W, Talwar N, Lee PP, Stein JD. Association of vision loss with hospital use and costs among older adults. JAMA Ophthalmol. 2019; https://doi.org/10.1001/jamaophthalmol.2019.0446. [Epub ahead of print].

  9. Wysong A, Lee PP, Sloan FA. Longitudinal incidence of adverse outcomes of age-related macular degeneration. Arch Ophthalmol. 2009;127(3):320–7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Carrière I, Delcourt C, Daien V, Pérès K, Féart C, Berr C, Ancelin ML, Ritchie K. A prospective study of the bi-directional association between vision loss and depression in the elderly. J Affect Disord. 2013;151(1):164–70.

    Article  PubMed  Google Scholar 

  11. Evans JR, Fletcher AE, Wormald RP. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114(2):283–8.

    Article  PubMed  Google Scholar 

  12. Nollett CL, Bray N, Bunce C, Casten RJ, Edwards RT, Hegel MT, Janikoun S, Jumbe SE, Ryan B, Shearn J, Smith DJ, Stanford M, Xing W, Margrain TH. High prevalence of untreated depression in patients accessing low-vision services. Ophthalmology. 2016;123(2):440–1.

    Article  PubMed  Google Scholar 

  13. van der Aa HP, Comijs HC, Penninx BW, van Rens GH, van Nispen RM. Major depressive and anxiety disorders in visually impaired older adults. Invest Ophthalmol Vis Sci. 2015;56(2):849–54.

    Article  PubMed  Google Scholar 

  14. Goldstein JE, Massof RW, Deremeik JT, Braudway S, Jackson ML, Kehler KB, Primo SA, Sunness JS, Low Vision Research Network Study Group. Baseline traits of low vision patients served by private outpatient clinical centers in the United States. Arch Ophthalmol. 2012;130(8):1028–37.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Renieri G, Pitz S, Pfeiffer N, Beutel ME, Zwerenz R. Changes in quality of life in visually impaired patients after low-vision rehabilitation. Int J Rehabil Res. 2013;36(1):48–55.

    Article  PubMed  Google Scholar 

  16. Mathew RS, Delbaere K, Lord SR, Beaumont P, Vaegan, Madigan MC. Depressive symptoms and quality of life in people with age- related macular degeneration. Ophthalmic Physiol Opt. 2011;31(4):375–80.

    Article  PubMed  Google Scholar 

  17. Frank CR, Xiang X, Stagg BC, Ehrlich JR. Longitudinal associations of self-reported vision impairment with symptoms of anxiety and depression among older adults in the United States. JAMA Ophthalmol. 2019; https://doi.org/10.1001/jamaophthalmol.2019.1085. [Epub ahead of print].

  18. Dawson SR, Mallen CD, Gouldstone MB, Yarham R, Mansell G. The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data. BMC Ophthalmol. 2014;14:78.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zhang X, Bullard KM, Cotch MF, Wilson R, Rovner BW, McGwin G, Owsley C, Barker L, Crews JE, Saaddine JB. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005–2008. JAMA Ophthalmol. 2013;131(5):573–81.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Zheng Y, Wu X, Lin X, Lin H. The prevalence of depression and depressive symptoms among eye disease patients: a systematic review and meta-analysis. Sci Rep. 2017;7:46453.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Huang CQ, Dong BR, Lu ZC, Yue JR, Liu QX. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev. 2010;9(2):131–41.

    Article  PubMed  Google Scholar 

  22. Huang C, Dong B, Lu Z, et al. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev. 2010;9:131–41.

    Article  PubMed  Google Scholar 

  23. Bookwala J, Lawson B. Poor vision, functioning, and depressive symptoms: a test of the activity restriction model. Gerontologist. 2011;51(6):798–808.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Rovner BW, Casten RJ. Activity loss and depression in age-related macular degeneration. Am J Geriatr Psychiatry. 2002;10(3):305–10.

    Article  PubMed  Google Scholar 

  25. Brown RL, Barrett AE. Visual impairment and quality of life among older adults: an examination of explanations for the relationship. J Gerontol B Psychol Sci Soc Sci. 2011;66(3):364–73.

    Article  PubMed  Google Scholar 

  26. Sieu N, Katon W, Lin EH, Russo J, Ludman E, Ciechanowski P. Depression and incident diabetic retinopathy: a prospective cohort study. Gen Hosp Psychiatry. 2011;33(5):429–35.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Rees G, Xie J, Fenwick EK, Sturrock BA, Finger R, Rogers SL, Lim L, Lamoureux EL. Association between diabetes-related eye complications and symptoms of anxiety and depression. JAMA Ophthalmol. 2016;134(9):1007–14.

    Article  PubMed  Google Scholar 

  28. Roy MS, Roy A, Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom Med. 2007;69(6):537–42.

    Article  PubMed  Google Scholar 

  29. Jones G, Rovner B, Crews J, Danielson M. Effects of depressive symptoms on health behavior practices among older adults with vision loss. Rehabil Psychol. 2009;54:64–172.

    Article  Google Scholar 

  30. Rovner BW, Casten RJ. Neuroticism predicts depression and disability in age-related macular degeneration. J Am Geriatr Soc. 2001;49:1097–100.

    Article  CAS  PubMed  Google Scholar 

  31. Brody BL, Gamst AC, Williams RA, et al. Depression, visually acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108:1893–901.

    Article  CAS  PubMed  Google Scholar 

  32. Shmuely-Dulitzki Y, Rovner BW, Zisselman P. The impact of depression on functioning in elderly patients with low vision. Am J Geriatr Psychiatry. 1995;3:325–9.

    Article  PubMed  Google Scholar 

  33. Rovner BW, Casten RJ, Hegel MT, Tasman WS. Minimal depression and vision function in age-related macular degeneration. Ophthalmology. 2006 Oct;113(10):1743–7.

    Article  PubMed  Google Scholar 

  34. Horowitz A, Reinhardt JP, Kennedy G. Major and subthreshold depression among older adults seeking vision rehabilitation services. Am J Geriatr Psychiatry. 2005;13:180–7.

    Article  PubMed  Google Scholar 

  35. Horowitz A, Brennan M, Reinhardt JP, Macmillan T. The impact of assistive device use on disability and depression among older adults with age-related vision impairments. J Gerontol B Psychol Sci Soc Sci. 2006;61(5):S274–80.

    Article  PubMed  Google Scholar 

  36. Horowitz A, Reinhardt JP, Boerner K. The effect of rehabilitation on depression among visually disabled older adults. Aging Ment Health. 2005;9(6):563–70.

    Article  CAS  PubMed  Google Scholar 

  37. Horowitz A, Reinhardt JP. Adequacy of the mental health system in meeting the needs of adults who are visually impaired. J Vis Impair Blind. 2006;100:871–4.

    Article  Google Scholar 

  38. Rees G, Ponczek E, Hassell J, Keeffe J, Lamoureux E. Psychological outcomes following interventions for people with low vision: a systematic review. Expert Rev Ophthalmol. 2010;5(3):385–403.

    Article  Google Scholar 

  39. Roets-Merken LM, Draskovic I, van Erp WS, Graff MJ, Kempen GI, Vernooij-Dassen MJ. Effectiveness of rehabilitation interventions in improving emotional and functional status in hearing or visually impaired older adults: a systematic review with meta-analyses. Clin Rehabil. 2015;29(2):107–19.

    Article  PubMed  Google Scholar 

  40. Owsley C, McGwin G, Lee PP, Wasserman N, Searcey K. Characteristics of low-vision rehabilitation services in the United States. Arch Ophthalmol. 2009;127(5):681–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Casten R, Rovner B, Fontenot J. Targeted vision function goals and low vision resource use in ophthalmology patients with age-related macular degeneration and comorbid depressive symptoms. J Vis Impair Blind. 2016;10:413–24.

    Article  Google Scholar 

  42. Tolman J, Hill RD, Kleinschmidt JJ, Gregg CH. Psychosocial adaptation to visual impairment and its relationship to depressive affect in older adults with age-related macular degeneration. Gerontologist. 2005;45(6):747–53.

    Article  PubMed  Google Scholar 

  43. van der Aa HP, Hoeben M, Rainey L, van Rens GH, Vreeken HL, van Nispen RM. Why visually impaired older adults often do not receive mental health services: the patient’s perspective. Qual Life Res. 2015;24:969–78.

    Article  PubMed  Google Scholar 

  44. Holloway EE, Sturrock BA, Lamoureux EL, Keeffe JE, Rees G. Depression screening among older adults attending low-vision rehabilitation and eye-care services: characteristics of those who screen positive and client acceptability of screening. Australas J Ageing. 2015;34(4):229–34.

    Article  PubMed  Google Scholar 

  45. Holloway EE, Sturrock BA, Lamoureux EL, Keeffe JE, Rees G. Help seeking among vision-impaired adults referred to their GP for depressive symptoms: patient characteristics and outcomes associated with referral uptake. Aust J Prim Health. 2015;21(2):169–75.

    Article  PubMed  Google Scholar 

  46. van der Aa HP, Krijnen-de Bruin E, van Rens GH, Twisk JW, van Nispen RM. Watchful waiting for subthreshold depression and anxiety in visually impaired older adults. Qual Life Res. 2015;24(12):2885–93.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Rees G, Fenwick E, Keeffe JE, Mellor D, Lamoureux EL. Managing depression in patients with vision impairment: a descriptive study of practitioners’ beliefs and confidence. Australas J Ageing. 2011;30(3):130–5.

    Article  PubMed  Google Scholar 

  48. Rees G, Mellor D, Heenan M, Fenwick E, Keeffe JE, Marella M, Lamoureux EL. Depression training program for eye health and rehabilitation professionals. Optom Vis Sci. 2010;87(7):494–500.

    Article  PubMed  Google Scholar 

  49. van Nispen RM, Vreeken HL, Comijs HC, Deeg DJ, van Rens GH. Role of vision loss, functional limitations and the supporting network in depression in a general population. Acta Ophthalmol. 2016;94(1):76–82.

    Article  PubMed  Google Scholar 

  50. Zheng DD, Bokman CL, Lam BL, Christ SL, Swenor BK, West SK, Muñoz BE, Tannenbaum SL, Lee DJ. Longitudinal relationships between visual acuity and severe depressive symptoms in older adults: the Salisbury Eye Evaluation Study. Aging Ment Health. 2016;20(3):295–302.

    Article  PubMed  Google Scholar 

  51. Holloway EE, Xie J, Sturrock BA, Lamoureux EL, Rees G. Do problem-solving interventions improve psychosocial outcomes in vision impaired adults: a systematic review and meta-analysis. Patient Educ Couns. 2015;98(5):553–64.

    Article  PubMed  Google Scholar 

  52. van der Aa HP, Margrain TH, van Rens GH, Heymans MW, van Nispen RM. Psychosocial interventions to improve mental health in adults with vision impairment: systematic review and meta-analysis. Ophthalmic Physiol Opt. 2016;36(5):584–606.

    Article  PubMed  Google Scholar 

  53. Rovner BW, Casten RJ, Hegel MT, Leiby BE, Tasman WS. Preventing depression in age-related macular degeneration. Arch Gen Psychiatry. 2007;64(8):886–92.

    Article  PubMed  Google Scholar 

  54. Rees G, Xie J, Chiang PP, Larizza MF, Marella M, Hassell JB, Keeffe JE, Lamoureux EL. A randomised controlled trial of a self-management programme for low vision implemented in low vision rehabilitation services. Patient Educ Couns. 2015;98(2):174–81.

    Article  PubMed  Google Scholar 

  55. Brody BL, Roch-Levecq AC, Gamst AC, Maclean K, Kaplan RM, Brown SI. Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol. 2002;120:1477–83.

    Article  PubMed  Google Scholar 

  56. Birk T, Hickl S, Wahl HW, Miller D, Kammerer A, Holz F, Becker S, Völcker H. Development and pilot evaluation of a psychological intervention program for patients with age-related macular degeneration. Gerontologist. 2004;44:836–43.

    Article  PubMed  Google Scholar 

  57. Wahl HW, Kämmerer A, Holz F, Miller D, Becker S, Kaspar R, Himmelsbach I. Psychosocial intervention for age-related macular degeneration: a pilot project. J Vis Impair Blind. 2006;100(9):533–44.

    Article  Google Scholar 

  58. Morse AR. Addressing the maze of vision loss and depression. AMA Ophthalmol. 2019; https://doi.org/10.1001/jamaophthalmol.2019.1234. [Epub ahead of print].

  59. Girdler SJ, Boldy DP, Dhaliwal SS, Crowley M, Packer TL. Vision self-management for older adults: a randomised controlled trial. Br J Ophthalmol. 2010;94(2):223–8.

    Article  PubMed  Google Scholar 

  60. Nollett CL, Bray N, Bunce C, Casten RJ, Edwards RT, Hegel MT, Janikoun S, Jumbe SE, Ryan B, Shearn J, Smith DJ, Stanford M, Xing W, Margrain TH. Depression in Visual Impairment Trial (DEPVIT): a randomized clinical trial of depression treatments in people with low vision. Invest Ophthalmol Vis Sci. 2016;57(10):4247–54.

    Article  PubMed  Google Scholar 

  61. Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, Tasman WS. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014;121(11):2204–11.

    Article  PubMed  Google Scholar 

  62. Wahl, HW. The psychological challenge of late-life vision impairment: concepts, findings, and practical implications. J Ophthalmol. 2013; Article ID 278135, 11 pages. https://doi.org/10.1155/2013/278135.

  63. Schilling OK, Wahl HW, Boerner K, Reinhardt JP, Brennan M, Horowitz A. Change in psychological control in visually impaired older adults over 2 years: role of functional ability and depressed mood. J Gerontol B Psychol Sci Soc Sci. 2012;68(5):750–61.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Gobeille M, Malkin A, Jamara R, Ross NC. Clinical outcomes of low vision rehabilitation delivered by a mobile clinic. Ophthalmic Physiol Opt. 2018;38(2):193–202.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Morris JC. Dementia update 2005. Alzheimer Dis Assoc Disord. 2005;19:100–11.

    Article  PubMed  Google Scholar 

  66. Lee CS, Larson EB, Gibbons LE, Lee AY, McCurry SM, Bowen JD, McCormick WC, Crane PK. Associations between recent and established ophthalmic conditions and risk of Alzheimer’s disease. Alzheimers Dement. 2019;15(1):34–41.

    Article  PubMed  Google Scholar 

  67. Davies-Kershaw HR, Hackett RA, Cadar D, Herbert A, Orrell M, Steptoe A. Vision impairment and risk of dementia: findings from the English Longitudinal Study of Ageing. J Am Geriatr Soc. 2018;66(9):1823–9.

    Article  PubMed  Google Scholar 

  68. Zheng DD, Swenor BK, Christ SL, West SK, Lam BL, Lee DJ. Longitudinal associations between visual impairment and cognitive functioning: the Salisbury Eye Evaluation Study. JAMA Ophthalmol. 2018;136(9):989–95.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Klaver CCW, Ott A, Hofman A, Assink JM, Bereteler MMB, de Jong PT. Is age-related maculopathy associated with Alzheimer’s disease?: the Rotterdam study. Am J Epidemiol. 1999;150:963–8.

    Article  CAS  PubMed  Google Scholar 

  70. Yoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest. 2005;115:2793–800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer’s disease. J Clin Invest. 2005;115:1–9.

    Article  Google Scholar 

  72. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med. 1986;315:485–7.

    Article  CAS  PubMed  Google Scholar 

  73. Schmidt S, Klaver CCW, Saunders AM, Postel EA, DeLaPaz MA, et al. A pooled case-controlled study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet. 2002;23:209–23.

    Article  PubMed  Google Scholar 

  74. Bird TD. Genetic factors in Alzheimer’s disease. N Engl J Med. 2005;352:862–4.

    Article  CAS  PubMed  Google Scholar 

  75. Qiu C, Sigurdsson S, Zhang Q, Jonsdottir MK, Kjartansson O, et al. Diabetes, markers of brain pathology and cognitive function: the age, gene/environment susceptibility–Reykjavik study. Ann Neurol. 2014;75(1):138–46.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Whitson HE, Cronin-Golomb A, Cruickshanks KJ, Gilmore GC, Owsley C, Peelle JE, Recanzone G, Sharma A, Swenor B, Yaffe K, Lin FR. American Geriatrics Society and National Institute on Aging bench-to-bedside conference: sensory impairment and cognitive decline in older adults. J Am Geriatr Soc. 2018;66(11):2052–8.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Rovner BW, Casten RJ, Leiby BE, Tasman WS. Activity loss is associated with cognitive decline in age-related macular degeneration. Alzheimers Dement. 2009;5(1):12–7.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Rovner BW, Casten RJ, Hegel MT, Leiby B. Preventing cognitive decline in black individuals with mild cognitive impairment: a randomized clinical trial. JAMA Neurol. 2018;75(12):1487–93.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Goldstein JE, Chun MW, Fletcher DC, Deremeik JT, Massof RW, Low Vision Research Network Study Group. Visual ability of patients seeking outpatient low vision services in the United States. JAMA Ophthalmol. 2014;132(10):1169–77.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Whitson HE, Whitaker D, Sanders LL, Potter GG, Cousins SW, Ansah D, McConnell E, Pieper CF, Landerman L, Steffens DC, Cohen HJ. Memory deficit associated with worse functional trajectories in older adults in low-vision rehabilitation for macular disease. J Am Geriatr Soc. 2012;60(11):2087–92.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Whitson HE, Whitaker D, Potter G, McConnell E, Tripp F, Sanders LL, Muir KW, Cohen HJ, Cousins SW. A low-vision rehabilitation program for patients with mild cognitive deficits. JAMA Ophthalmol. 2013;131(7):912–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robin J. Casten .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Casten, R.J., Rovner, B.W. (2021). Psychiatric and Psychosocial Factors in Low Vision Rehabilitation. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_242-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90495-5_242-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90495-5

  • Online ISBN: 978-3-319-90495-5

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics